Login
Toggle navigation
Videos
Categories
Trending
Fubo CEO David Gandler discusses the company's 4Q earnings and the competitive landscape of sports streaming with Diane King Hall.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Gandler is Co-founder and CEO of FuboTV Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Analyzing Market Opportunities: Insights into the Foord Equity Fund | Cobie Legrange - Fundamental Analyst, Acsis
00:10:00
Northern Graphite Investor Event: Market Insights & Corporate Overview (Jan 18, 2024) | Hugues Jacquemin, Chief Executive Officer of Northern Graphite Corporation
00:10:00
mWell CEO and MPIC Chief Finance, Risk, and Sustainability Officer Maria discusses #foodandnutrition initiatives at Metro Pacific Investments Corporation.
00:10:00
Navigating Economic Challenges: Scott Kapnick on Deploying Private Debt Capital |Scott Kapnick, CEO, HPS Investment Partners
00:10:00
Sprott Resource Holdings Focuses on Copper Growth at Manantiales de Oro Mine in Chile
00:10:00
Future of Global Finance: An Interview with Marc Rowan - Marc Rowan | Co-Founder and CEO, Apollo Global Management, Inc.
00:10:00
Paul Bibby of A-Core Resources Discusses Iron Ore Potential and Future Plans at Mining Investment Event in Hong Kong
00:10:00
Creating a Binge-Worthy Investor Pitch: Enhancing Mining Presentations with VRIFY
00:10:00
Salt Lake Potash: Advancing Potash Projects at One-to-One Mining Conference in London
00:10:00
American Lithium Explores New Frontiers in Lithium Discovery at One-to-One Mining Investment Sydney Event
00:10:00
Financing Strategies for Junior Mining Companies in 2024
00:10:00
The Critical Need for Historical Knowledge in Military Strategy